A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, ...
A team at Texas A&M University has developed an automated system for separating and shipping At-211. This patent-pending device enables the radioisotope to be purified and loaded as part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results